why choose us

First received: July 14, 2022

Clinical Trial: Intranasal Insulin for COVID-19-related Smell Loss

Study Status: Completed

Recruit Status: Completed

Condition: Anosmia
Smell Loss
Paraosmia
Hyposmia
COVID-19

Study Type: Interventional


Official Title: Intranasal Insulin for COVID-19-related Smell Loss

Brief Summary: The aim of this study was to quantify the improvement in olfaction of 27 post-COVID-19 patients, after three intreventions of intranasal insulin during a four week period, with the help of the Threshold, Discrimination and Identification (TDI) score evaluated with Sniffin Sticks®.

Read more